Datum: 2.3.2009
Researchers at the Dana-Farber Cancer Institute (Dana-Farber), Burnham Institute for Medical Research (Burnham) and the Centers for Disease Control and Prevention (CDC) have reported the identification of human monoclonal antibodies (mAb) that neutralize an unprecedented range of influenza A viruses, including avian influenza A (H5N1) virus, previous pandemic influenza viruses, and some seasonal influenza viruses.
These antibodies have the potential for use in combination with other treatments to prevent or treat certain types of avian and seasonal flu. The study was published online on February 22 in Nature Structural and Molecular Biology.
Burnham Institute for Medical Research
Seminář - Odstranění toxických polutantů z odpadních vod
BioInova, Praha, Česká republika, September 07, 2010
Národní informační den Regiony znalostí a výzkumný potenciál: Aktuální výzvy pro rok 2011
Aula rektorátu VUT, Antonínská 1, Brno, ČR, September 14, 2010
České fórum pro výzkum, vývoj a inovace 2010
Budova E, Mendelova univerzita v Brně, Brno, Česká republika, September 23, 2010
Trends in Nanotechnology International Conference (TNT2010)
Braga, Portugal, September 06-10, 2010
Protein Engineering
Greifswald, Germany, September 06-10, 2010
2010 International Conference on Environmental Engineering and Applications
(ICEEA 2010)
Singapore, September 10-12, 2010
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
© 2006 - 2010 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Life Sciences Search engine - Huge database of genome, protein, gene, genome project, ..
Science Daily - Science Magazine
Past, presence and future of the surveillance of the congenital anomalies
Vaccine-Delivery Patch With Dissolving Microneedles Eliminates 'Sharps,' Boosts Protection